A strong case for third-party testing.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37962204.
- Also identified by DOI 10.7554/eLife.93329 and PMC identifier 10645416.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A strategy to identify high-quality commercially available antibodies for research reveals extensive use of non-specific antibodies and offers solutions for future large-scale testing.
Medical subject headings
- Antibodies